subgroup
of
cancer)
→
ReceivesAction
→
followed by prostate cancer
Typicality: | 0.299 |
Saliency: | 0.320 |
in breast cancer | 3 | other |
in females | 2 | other |
lung cancer → be followed by → prostate cancer | 6 |
lung cancer → rank → prostate cancer | 3 |
negative | neutral | positive |
0.757 | 0.226 | 0.017 |
Raw frequency | 9 |
Normalized frequency | 0.320 |
Modifier score | 0.500 |
Perplexity | 38.604 |